Responding to a need for better post-market surveillance of orthopedic devices, the U.S. Food and Drug Administration (FDA) established the International Consortium of Orthopaedic Registries (ICOR) in October 2010.

The Board of Trustees of NewYork-Presbyterian Hospital announced today that it has named Steven J. Corwin, M.D., as the new Chief Executive Officer of the Hospital. Dr. Corwin succeeds Herbert Pardes, M.D., who is retiring as head of the Hospital and will become Executive Vice Chairman of the Board of Trustees. The Board also announced that Robert E. Kelly, M.D., has been named President of the Hospital, reporting to Dr. Corwin. The new appointments follow a national search by a committee of the Board of Trustees and are effective Sept. 6, 2011.

Dr. Michael Stewart has been named the editor-in-chief of The Laryngoscope, a prestigious academic journal that has been the forum for many groundbreaking advances in the specialty of otolaryngology–head and neck surgery

An authority in neonatal congenital anomalies, pediatric thoracic surgery and pediatric surgical oncology, Dr. Nitsana Spigland has been appointed chief of pediatric surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. She is associate professor of surgery and associate director of medical student education at Weill Cornell Medical College.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center today celebrated the opening of the Jill Roberts Center for Inflammatory Bowel Disease. Made possible through a $4 million gift from Jill Roberts, a long-standing friend and patron of NewYork-Presbyterian Hospital and Weill Medical College of Cornell University, the Center will support patient care, research and educational outreach focused on the conditions of Crohn's disease and ulcerative colitis.

NewYork-Presbyterian Hospital is #1 in the New York City metropolitan area and #6 in the nation, according to U.S. News Media Group's 2009-2010 edition of America's Best Hospitals. This is the sixth consecutive year the Hospital ranks among the top 10 in the nation.

In searching for a simple way to identify individuals with smoking-related lung injury, scientists at Weill Cornell Medical College have stumbled upon a potential explanation for why the class of pain-relievers known as COX-2 inhibitors increases the risk of heart problems among users.

Breast cancer specialists at NewYork-Presbyterian Hospital/Columbia University Medical Center are offering patients new ways to detect early signs of lymphedema, a common side effect of breast cancer surgery that causes painful, debilitating and disfiguring swelling in the arms following removal of lymph nodes.